A detailed history of Graham Capital Management, L.P. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Graham Capital Management, L.P. holds 2,502 shares of ASND stock, worth $321,256. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,502
Holding current value
$321,256
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$121.07 - $153.67 $302,917 - $384,482
2,502 New
2,502 $341,000
Q2 2022

Aug 15, 2022

BUY
$78.08 - $117.61 $739,105 - $1.11 Million
9,466 New
9,466 $879,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.17B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.